The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of bortezomib, lenalidomide and dexamethasone (VRd) to treat multiple myeloma in adults. Sarclisa ...

Banking Industries for FICO, offers insights to help motor finance companies get ready to meet the regulatory requirements, ...

When the job search feels hopeless, these financial strategies can help you stay grounded and focused until the right opportunity lands.